Omics profile of iPSC-derived astrocytes from Progressive Supranuclear Palsy (PSP) patients (2023)
- Authors:
- Autor USP: RONSEIN, GRAZIELLA ELIZA - IQ
- Unidade: IQ
- DOI: 10.1016/j.parkreldis.2023.105847
- Subjects: ASTRÓCITOS; DOENÇAS NEURODEGENERATIVAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Parkinsonism and Related Disorders
- ISSN: 1353-8020
- Volume/Número/Paginação/Ano: v. 116, p. 1-12, art. 105847, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
RAVAGNANIA, Felipe G et al. Omics profile of iPSC-derived astrocytes from Progressive Supranuclear Palsy (PSP) patients. Parkinsonism and Related Disorders, v. 116, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.parkreldis.2023.105847. Acesso em: 23 jan. 2026. -
APA
Ravagnania, F. G., Valerio, H. P., Maués, J. H. S., Oliveira, A. N. de, Puga, R. D., Oliveira, K. G., et al. (2023). Omics profile of iPSC-derived astrocytes from Progressive Supranuclear Palsy (PSP) patients. Parkinsonism and Related Disorders, 116, 1-12. doi:10.1016/j.parkreldis.2023.105847 -
NLM
Ravagnania FG, Valerio HP, Maués JHS, Oliveira AN de, Puga RD, Oliveira KG, Picosse FR, Ferraz HB, Catharino RR, Ronsein GE, Aguiar PM de C. Omics profile of iPSC-derived astrocytes from Progressive Supranuclear Palsy (PSP) patients [Internet]. Parkinsonism and Related Disorders. 2023 ; 116 1-12.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1016/j.parkreldis.2023.105847 -
Vancouver
Ravagnania FG, Valerio HP, Maués JHS, Oliveira AN de, Puga RD, Oliveira KG, Picosse FR, Ferraz HB, Catharino RR, Ronsein GE, Aguiar PM de C. Omics profile of iPSC-derived astrocytes from Progressive Supranuclear Palsy (PSP) patients [Internet]. Parkinsonism and Related Disorders. 2023 ; 116 1-12.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1016/j.parkreldis.2023.105847 - Cholesterol efflux capacity and subclasses of HDL particles in healthy women transitioning through menopause
- Plasminogen promotes cholesterol efflux by the ABCA1 pathway
- Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients
- Targeted proteomics identifies Paraoxonase/Arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone
- Niacin therapy increases high-density lipoprotein particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects
- Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway
- Oxidação do triptofano pelo oxigenio molecular no estado singlete [´OIND.2´(´ANTPOT.1´DELTA IND.g´)]: estudos mecanisticos envolvendo marcação isotopica, espectrometria de massa e quimiluminescencia
- Patients with coronary endothelial dysfunction have impaired cholesterol efflux capacity and reduced HDL particle concentration
- Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles
- Niacin increases atherogenic proteins in high-density lipoprotein of statin-treated subjects
Informações sobre o DOI: 10.1016/j.parkreldis.2023.105847 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3157906.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
